Costs of ALK, ROS1, EGFR, and KRAS testing in non-small cell lung cancer: About different strategies in France

Cancer Cytopathol. 2017 Nov;125(11):876. doi: 10.1002/cncy.21919. Epub 2017 Sep 11.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Carcinoma, Non-Small-Cell Lung*
  • ErbB Receptors
  • France
  • Humans
  • Lung Neoplasms*
  • Protein-Tyrosine Kinases
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins p21(ras)
  • Receptor Protein-Tyrosine Kinases

Substances

  • KRAS protein, human
  • Proto-Oncogene Proteins
  • EGFR protein, human
  • ErbB Receptors
  • Protein-Tyrosine Kinases
  • ROS1 protein, human
  • Receptor Protein-Tyrosine Kinases
  • Proto-Oncogene Proteins p21(ras)